Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

A flat end to the day
Mon, 10 Nov Closing

Indian share markets had a volatile outing today. After opening firm, the key indices slipped in the red for most part of the day but recovered in the closing hours to end the day marginally positive. BSE-Sensex closed higher by 6 points and NSE-Nifty closed higher by 7 points. BSE Mid Cap ended 0.1% up and BSE Small Cap index closed higher by 0.2%. FMCG and consumer durable stocks were the major gainers today.

On the global front, the Asian markets largely ended the day on a positive note. The rupee is trading at 61.48 to the US dollar.

Majority of the energy stocks ended the day in the green. MRPL and Indraprastha Gas were the major gainers today. According to a leading financial daily, the Oil Ministry has sought cash subsidy of Rs 81.8 bn from the government to compensate 33% of the losses suffered by retailers like Indian Oil Corporation (IOC), Bharat Petroleum Corporation (BPCL) and Hindustan Petroleum Corporation (HPCL) for selling diesel and cooking gas at subsidized rates for the September 2014 quarter. The three companies reported a revenue loss of Rs 245.6 bn in the quarter. Upstream oil and gas producers such as ONGC, Oil India and GAIL will contribute the balance Rs 163.8 bn towards the losses suffered by retailers.

Most of the foreign pharma companies ended the day on a mixed note. Sanofi and Fulford India were the biggest gainers. As per a leading financial daily, Sanofi's vaccine division Sanofi Pasteur has launched a paediatric pentavalent vaccine Shan5 in India. The vaccine has been developed and manufactured by Sanofi's affiliate Shantha. The vaccine provides protection to children against five diseases namely diphtheria, tetanus, pertussis, Hib and hepatitis B. The World Health Organization has given prequalification status to the launch of Shan5 vaccine. This criterion will help the company secure the market for such vaccines in 50 emerging and low-income countries.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "A flat end to the day". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.